DANVERS, Mass., May 19, 2014 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, notes that there will be approximately eight potential Impella-related presentations in the scientific sessions at the annual EuroPCR 2014 cardiovascular course, scheduled from May 20 - 23, 2014 at the Palais Des Congrès de Paris.
Help employers find you! Check out all the jobs and post your resume.
